The right clinical trial tech stack isn’t the most complete one; it’s the one built with sites, funded fairly, and designed to remove friction, not add it.
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
What's Trending In The Biopharma And Biotech Industries
With improved access to affordable digital technologies and a regulatory emphasis on diversity in patient recruitment, check out several highlights of the most notable projections in 2023.
-
How Digital Therapeutics Tools Interact To Improve Patient Care
This comprehensive overview illustrates the intersection between prescription digital therapeutics, digital health tools, and decentralized clinical trials in a remote care setting.
-
Breaking Down Barriers: Why Closed Technology Ecosystems Are Holding Back Clinical Research
Explore the barriers created by closed technology ecosystems and the importance of open, interoperable solutions for advancing healthcare.
-
Training Program Reduces Placebo Effect By More Than 50% In ePRO Study
Discover how an instruction program directly contributed to significantly lowering the placebo response rate in a phase III migraine CNS study.
-
Understanding Security And Role-Based Access In An eTMF Platform
Most unauthorized data breaches enter through doors that already exist. Learn how role-based access can improve security by tailoring access to each user’s needs and responsibilities.
-
Taming The Complex Clinical-Trial Ecosystem
To navigate the growing number of vendor portals required for clinical trials, sites are seeking a vendor- and sponsor-agnostic solution to enable single sign-on and study organization.
-
It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies
CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.
-
Bringing Clinical Research To The Patient Using Patient-Centric Tech
By fostering daily interactions between patients and technology, these smart hubs offer a sustainable approach to ensuring the success and integrity of clinical trials in an evolving landscape of drug development.
-
Overcoming Real-World Data Capture Challenges In Phase 4 Trials
As the demand for real-world insights continues to grow, learn why navigating challenges and leveraging emerging opportunities becomes crucial for advancing clinical research in the real-world setting.
-
Revolutionizing Pediatric Clinical Trials With ePRO And eConsent
Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
RECENT NEWSLETTERS
- 06.18.26 -- AI, eSource, And Site Tech: What's Actually Working In Trials
- 06.11.26 -- AI Governance, Site Tech Risk, And Trial Efficiency Gains
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works